Fulcrum BioEnergy arrived in Gary with great fanfare in 2018, promising $600 million in investment, 160 jobs and what turned out to be sty-in-the-sky plans to turn trash into jet fuel.

Dr. Kelly YiYu Lin Joins Fulcrum Wealth Advisors as Chief Economist BELLEVUE, WASHINGTON - March 12, 2026 (NEWMEDIAWIRE) - Fulcrum Wealth Advisors, a prominent wealth management firm located in ...

Fulcrum Wealth Advisors, a leading wealth management firm in Bellevue, today announced the appointment of Dr. Kelly YiYu Lin as Chief Economist. Dr. Lin brings deep expertise in macroeconomic research ...

San Francisco, CA /PRNewswire/ - Fulcrum, the AI-powered field process management and data collection platform, today announced it has acquired Wildnote, an environmental software company focused on ...

SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Fulcrum, the AI-powered field process management and data collection platform, today announced the launch of Insights, a new AI-based capability that lets ...

Mumbai, January 28, 2026 — Fulcrum, an insurtech startup founded by Indian-origin entrepreneurs Arjun Mangla and Sambhav Anand, has raised $25 million in combined Seed and Series A funding in a round ...

Fulcrum, the leading AI platform for insurance brokerages, on Wednesday, January 28, announced $25 million in combined seed and series A funding. The company said the funding was led by CRV, with ...

US-based insurance automation company Fulcrum has secured $25m across seed and Series A funding rounds as it looks to broaden adoption of its software among large brokerage houses. The financing was ...

Used by many of the top U.S. brokerages, Fulcrum’s AI platform cuts policy delivery from 15 days to same-day turnarounds and proposals down from eight hours to as little two Fulcrum, the leading AI ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Fulcrum Therapeutics (FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease. “We are highly ...